On September 16, 2019 ImmunoPrecise Antibodies reported that it will participate in the 17th Annual Discovery on Target (DOT) being held Boston, MA September 16-19 (Press release, ImmunoPrecise Antibodies, SEP 16, 2019, View Source [SID1234539545]). With over 1,300 attendees and a variety of keynote speakers, training seminars, short courses, roundtables, and networking functions, DOT is said to be the industry’s preeminent event on novel drug target and technologies.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jennifer Bath, Ph.D., and Barry Duplantis, Ph.D., will be available at booth 308 to discuss with attendees how ImmunoPrecise Antibodies’ broad range of products and services, including our B cell Select antibody discovery platform, can streamline and accelerate their therapeutic antibody development efforts. Attendees can schedule a meeting with Jennifer or Barry by emailing Barry at [email protected] or by using the Brella networking app.